PDG11: HEALTH AND ECONOMIC OUTCOMES OF A NEW ORAL DIABETES DRUG, PIOGLITAZONE (ACTOS*NF, TAKEDA), IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN NORWAY
A Brandt, K Frislid, R Jansen, N Maniadakis, A KielhornVolume:
4
Year:
2001
Language:
english
DOI:
10.1016/s1098-3015(11)71748-x
File:
PDF, 52 KB
english, 2001